Cargando…
Immunomodulatory Mechanism and Potential Therapies for Perinatal Hypoxic-Ischemic Brain Damage
Hypoxia-ischemia (HI) is one of the most common causes of death and disability in neonates. Currently, the only available licensed treatment for perinatal HI is hypothermia. However, it alone is not sufficient to prevent the brain injuries and/or neurological dysfunction related to HI. Perinatal HI...
Autores principales: | Min, Ying-Jun, Ling, Eng-Ang, Li, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849181/ https://www.ncbi.nlm.nih.gov/pubmed/33536907 http://dx.doi.org/10.3389/fphar.2020.580428 |
Ejemplares similares
-
Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage
por: Bustelo, Martín, et al.
Publicado: (2020) -
Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury
por: de Cerio, Felipe Goñi, et al.
Publicado: (2013) -
Editorial: Perinatal hypoxic-ischemic brain injury: Mechanisms, pathogenesis, and potential therapeutic strategies
por: Chen, Xiaodi, et al.
Publicado: (2022) -
Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010) -
Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)